Showing results (141-150 of 147) with videos related to
Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Korean Journal of Internal Medicine|July 9, 2023
Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practiceYoung Jin Youn, Jun-Won Lee, Sung Gyun Ahn, et al.European Heart Journal. Cardiovascular Pharmacotherapy|January 30, 2023
Prasugrel dose de-escalation in diabetic patients with acute coronary syndrome receiving percutaneous coronary intervention: results from the HOST-REDUCE-POLYTECH-ACS trialKyu-Sun Lee, Keun-Ho Park, Kyung Woo Park, et al.Clinical Therapeutics|October 16, 2016
Blood Pressure and Cholesterol-lowering Efficacy of a Fixed-dose Combination With Irbesartan and Atorvastatin in Patients With Hypertension and Hypercholesterolemia: A Randomized, Double-blind, Factorial, Multicenter Phase III StudySang-Hyun Kim, Sang-Ho Jo, Sang-Cheol Lee, et al.Clinical Therapeutics|February 10, 2016
Efficacy and Safety of DP-R202 in Patients with Chronic Artery Occlusive Disease: Multicenter Randomized Double-blind Active-controlled Parallel Group Phase III Clinical StudyHan Cheol Lee, Sang-Rok Lee, Kyoo-Rok Han, et al.Journal of the American College of Cardiology|October 25, 2011
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trialKyung Woo Park, In-Ho Chae, Do-Sun Lim, et al.Circulation|December 20, 2011
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter studyHyeon-Cheol Gwon, Joo-Yong Hahn, Kyung Woo Park, et al.Clinical Therapeutics|July 13, 2015
Evaluation of the Efficacy and Safety of the Lercanidipine/Valsartan Combination in Korean Patients With Essential Hypertension Not Adequately Controlled With Lercanidipine Monotherapy: A Randomized, Multicenter, Parallel Design, Phase III Clinical TrialSang-Hoon Na, Hae-Young Lee, Sang Hong Baek, et al.Pageof 15